Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a drug combo free liver transplant patients from lifelong pills?

NCT ID NCT06832189

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times

Summary

This study tests whether two drugs, everolimus and epoetin, can help liver transplant recipients safely stop taking their standard anti-rejection medication (tacrolimus). The goal is to achieve 'operational tolerance,' where the body accepts the new liver without needing lifelong drugs. Twenty adults who are 1-10 years post-transplant and stable on tacrolimus will be enrolled. The main focus is safety, checking for infections, cancers, and serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Northwestern University Feinberg School of Medicine

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California San Francisco School of Medicine

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pennsylvania Medical Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.